EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $82,134 | -62.3% | 269,293 | -13.1% | 0.00% | – |
Q2 2023 | $218,100 | +1817400.0% | 309,801 | +2143.6% | 0.00% | – |
Q1 2023 | $12 | -98.7% | 13,808 | -98.2% | 0.00% | -100.0% |
Q4 2022 | $905 | -99.2% | 767,121 | +4328.8% | 0.00% | – |
Q3 2021 | $116,000 | -90.3% | 17,321 | -87.2% | 0.00% | -100.0% |
Q1 2021 | $1,194,000 | -36.7% | 134,865 | -12.2% | 0.00% | 0.0% |
Q4 2020 | $1,887,000 | +2044.3% | 153,542 | +1092.3% | 0.00% | – |
Q1 2020 | $88,000 | -74.0% | 12,878 | -43.3% | 0.00% | – |
Q4 2019 | $339,000 | -88.6% | 22,721 | -89.3% | 0.00% | -100.0% |
Q1 2019 | $2,970,000 | +1064.7% | 212,430 | +747.3% | 0.00% | – |
Q4 2018 | $255,000 | -70.7% | 25,072 | -64.9% | 0.00% | -100.0% |
Q2 2018 | $871,000 | +67.5% | 71,371 | +91.5% | 0.00% | 0.0% |
Q4 2017 | $520,000 | -5.5% | 37,265 | -25.5% | 0.00% | 0.0% |
Q3 2017 | $550,000 | +50.7% | 49,997 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $365,000 | – | 46,234 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
CAXTON CORP | 116,884 | $970,000 | 1.21% |